Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Compound was evaluated for inhibition of human PDE6A in an in vitro cell free assay measured by scintillation proximity assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 68 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of PDE6 (unknown origin) by 3H-cAMP scintillation proximity assay
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of PDE6 (unknown origin) assessed as inhibition constant
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
PDE5 Inhibition Assay from US Patent US10626113: "Phosphodiesterase inhibitors and uses thereof"
Assay data:14 Active, 4 Activity ≤ 1 nM, 14 Activity ≤ 1 µM, 14 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Selectivity interaction (PDE panel (enzymatic activity assay)) EUB0000751a PDE6A
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Selectivity interaction (PDE panel (enzymatic assay)) EUB0000744a PDE6A
SummaryRelated BioAssays by Target
Inhibition of PDE6 (unknown origin)
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
Inhibition of PDE6 (unknown origin) using FAM-cGMP or FAM-cAMP as substrate incubated for 60 mins and measured by fluorescence polarization assay
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of cAMP-specific 3',5'-cyclic phosphodiesterase (unknown origin)
Assay data:2 Active, 1 Activity ≤ 1 µM, 4 Tested
Inhibition of human PDE4 at 10 uM relative to control
Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP Assay
Assay data:8 Active, 8 Activity ≤ 1 nM, 8 Activity ≤ 1 µM, 8 Tested
PDE Enzyme Assay from US Patent US11453673: "Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors"
Assay data:2 Active, 16 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
Enzyme Assays from US Patent US11401274: "[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes"
Assay data:8 Active, 8 Activity ≤ 1 µM, 8 Tested
PDE Enzyme Assays Using [3H]cGMP as Substrate from US Patent US11180503: "[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives"
Assay data:8 Active, 2 Activity ≤ 1 µM, 13 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Inhibition Assay from US Patent US10899756: "Phosphodiesterase inhibitors and uses thereof"
Assay data:23 Active, 7 Activity ≤ 1 nM, 23 Activity ≤ 1 µM, 23 Tested
PDE6 CEREP ligand profiling
Biochemical assay (PDE6A)
Assay data:1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
hPDE6AB PDE scan
Inhibition of human PDE6
Assay data:2 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on